Singapore

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules.

Post : Asia Pacific Regional Management Center (RMC) Compliance Manager

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules.

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better. Our over 125,000 employees in 60 countries are united in a common mission: To help people everywhere live longer, healthier, happier lives.

Post : Assoc Director, Global Regulatory Affairs

The NGS Scholarship is awarded to talented students with an aptitude for innovative, high calibre PhD research.

Product Inspection Challenges for Multinational Pharmaceutical Organisations

ABOUT AUTHOR:
Neil Giles
Marketing Communications Manager,
Mettler-Toledo Product Inspection, UK

The global pharmaceutical industry is booming. While North America still leads production with 41% of world pharmaceutical sales, Europe is catching up with 26.7%.^[1] According to the European Federation of Pharmaceutical Industries and Associations, the European market alone generated more than 205 billion Euros in 2011, with Italy contributing about 25 billion.^[2] The worldwide healthcare industry is further boosted by growing market and research efforts in emerging economies such as Brazil, China and India, leading to a gradual migration of economic and research activities from Europe to these fast-growing markets.

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies